Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Gross Profit (2019 - 2024)

Updated

Entera Bio (ENTX) posted Gross Profit of $9,000 for FY2024.

Analysis

Entera Bio (ENTX) Gross Profit (2019 - 2024) Analysis & Trends

Since FY2020, Entera Bio has reported Gross Profit for 4 years.

  • Annual Gross Profit shows a four-year compound annual growth rate of -39.0% (FY2020 to FY2024).
  • Business Quant data shows ENTX's Gross Profit at $33,000 in FY2022 (-83.3%), $198,000 in FY2021 (+204.6%) and $65,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Entera Bio 563.51 Mn 269.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 9,000.00
Dec 31, 2022 6,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 11,000.00
Mar 31, 2022 14,000.00
Dec 31, 2021 29,000.00
Sep 30, 2021 75,000.00
Jun 30, 2021 10,000.00
Mar 31, 2021 84,000.00
Dec 31, 2020 25,000.00
Sep 30, 2020 19,000.00
Jun 30, 2020 21,000.00
Dec 31, 2019 -6,000.00
Sep 30, 2019 20,000.00
Jun 30, 2019 12,000.00
API Access

Entera Bio Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ENTX&period=max&api_key=YOUR_API_KEY